Abstract submission has now closed. If you have already submitted an abstract for ASCEPT-BPS 2015 and received your Access Key, you will only be able to view your submitted abstract/s.
You are invited to submit an abstract/s to be reviewed for inclusion in the conference programme as either an oral and/or poster presentation.
Oral presentations – 10 minutes duration with 5 minutes for questions
Poster presentations – posters will be on display, with authors in attendance at a specified day/time
Please choose one of the themes below that best describes your research area.
|BPS Affinity Groups / Meeting themes||Equivalent for ASCEPT members|
|Cardiovascular and Respiratory||Cardiovascular|
|Drug Discovery, Development and Evaluation||Clinical Pharmacology and Therapeutics, Drug Disposition and Response, Pharmacogenomics and Pharmacoepidemiology|
|Education and Skills||Education|
|Integrative and Systems Pharmacology||Urogenital and Gastrointestinal|
|Molecular and Cellular Pharmacology||Drug Discovery|
|Neuropharmacology||Neuropharmacology or Neuro- and Behavioural Pharmacology|
Successful authors are required to register and pay the appropriate registration fees for the conference, in order to ensure their abstract is included in the final programme.
Instructions to authors
Before proceeding to submit your abstract, please read the following author instructions to ensure you have all of the information that will be needed to complete the submission process. Please pay particular attention to these instructions as abstracts that do not conform will not be accepted by the editors.
Abstracts MUST be typed into the following MS Word template:
- Abstracts must be submitted via the online abstract submission site.
- Abstracts must be submitted on the word template.
- Do not change the page margins or any set up features.
- The abstract must be left-and right-justified.
- The abstract must fit within the space on the template provided.
- The abstract must not continue onto two pages.
- The abstract should be typed in Arial 10 point font (do not use “bold” type)
- All text should be entered in sentence case (do not type in CAPITAL LETTERS)
- If inserting colour tables and images into the template, please keep in mind that these may not reproduce well on a monotone printer, so it is preferable that the images used be suitable for black and white printing.
ABSTRACT GUIDELINES FOR AUTHORS
Please read the abstract submission guidelines carefully before submitting your abstract.
Ethical requirements By submitting the abstract the corresponding author confirms that the work meets the required ethical standards for experimentation: For research using animals / animal tissues, all procedures meet the following requirements as appropriate of the Animals (Scientific Procedures) Act 1986 / ASPA Amendment Regulations 2012 for work performed in the UK, or under the EU Directive 86/609/EEC, or for work carried out elsewhere, all procedures meet with current national legislation / guidelines or, in their absence, with local guidelines. For medical research involving human subjects, including research on identifiable human material and data, the World Medical Association (WMA) Declaration of Helsinki as a statement of ethical principles has been adhered to, and procedures concur with the standards set by the relevant national, institutional or other body responsible.
Abstracts submitted for scientific sessions should describe work that has not been published or presented at another national meeting. The selection of contributions for scientific sessions will depend on the quality of the abstract submitted.
Title box The title should be as brief as possible but long enough to indicate clearly the nature of the study. Capitalise the first letter of each word. No full stop at the end. Do not state the conclusion in your title.
Authors Starting on a new line, without a line-space to the Title, list the Presenting Author first, followed by other authors and contact details entered as directed in the template. Use a mixture of upper and lower case text, e.g., Geoffrey A Harrison, Peter L McCartney & James H Lennon. Do not use ‘bold’ or ‘underline’.
Addresses Follow the authors’ address details immediately after the names (ie., do not start a new line). Author’s department and institution should be abbreviated. Superscript numbers should be used to link the author(s) to their address(es) presented (e.g. Geoffrey A Harrison1, Peter L McCartney1,2. Dept of Pharmacol, Univ of Melbourne1, Parkville, VIC; Dept of Clin Pharmacol, Royal Melbourne Hosp2, Parkville, VIC).
Content Leave one line space after the Authors/addresses. Do not indent. Type as one block of text and include sub-headings: Introduction, Aims, Methods, Results and Discussion (including any conclusions drawn from results). Start each heading on a new line with text immediately following heading and without additional line spacing. The introduction must include a clear purpose or hypothesis. In general the methods should contain enough detail to allow others to repeat the study. Core methods papers may be cited. Species and strain (or human population characteristics) and group sizes must be indicated. Use of drugs (including anaesthetics) requires: solvent, dose and route of administration, or concentration. The discussion / conclusion should be comprehensible and logical, and not contain unjustified speculation.
Units Concentration – use either molar or mass units as most appropriate: nmol/L, μmol/L, mmol/L, etc.; or: ng/L, µg/L, mg/L, etc. Dose – use mg/kg, or mmol/kg, etc. Dose schedules – use mg/kg per day, or mmol/kg per day etc. Pressure – may be in mmHg, psi, Pascal, or Torr, etc, as appropriate. Tension – may be in “g”, etc.
Anaesthetic If an anaesthetic is used, it must be named along with the dose and route of administration.
Figures and tables The abstract may contain numerical data in the text or in a figure or table, and appropriate statistical analysis.
Statistics Use the format: mean±SEM (n= ; P<) e.g. 57±3 (n = 7, P<0.02). If ± is used to indicate anything other than a standard error, e.g., a range or standard deviation, this should be specified in the abstract. Where appropriate, authors should ensure consistency in the number of decimal places used.
References References must be indicated in the text as (1), (2) etc. and correspondingly cited at the end of the abstract in the following format:
Paper – author(s) (year). Journal
Volume: First page-Last page. as follows: single author: Smith AB (2012).
Br J Pharmacol 233: 666-673. two authors: Smith AB and Miller C (2011). Br J Pharmacol 355: 21-29. more than 2 authors: Smith AB et al. (2009). Br J Pharmacol 109: 85-95.
Book chapter – Smith AB (2005). In: Miller C (ed). Book title. Publisher: Location, pp 1-10.
Website page – IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1794.
Abbreviations Excessive use of abbreviations should be avoided. Nonstandard abbreviations should be defined. New drugs should include their full chemical name.